Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
China flag China · Delayed Price · Currency is CNY
20.12
-0.14 (-0.69%)
Feb 13, 2026, 3:04 PM CST

SHE:300482 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
205.18828.69840.31,163996.151,408
Short-Term Investments
-62.86623.04200.26--
Trading Asset Securities
1,4061,306722.45938.07572.73102.6
Cash & Short-Term Investments
1,6122,1982,1862,3011,5691,511
Cash Growth
-23.80%0.55%-5.00%46.66%3.84%54.09%
Accounts Receivable
1,0761,130599.87540.97501.78269.93
Other Receivables
87.244.2551.7266.664.768.38
Receivables
1,1631,174651.59607.57566.48338.31
Inventory
346.49359.56351.4399.97386.24376.66
Other Current Assets
154.154.1744.574263.944.41
Total Current Assets
3,2753,7863,2333,3502,5862,270
Property, Plant & Equipment
1,4851,4841,3531,189906.09676.63
Long-Term Investments
1,4031,391709.481,284971.421,025
Goodwill
111.42111.42111.42115.3742.5148.39
Other Intangible Assets
225.1205.51194.52203.71208.11180.19
Long-Term Deferred Tax Assets
71.2376.1857.4753.8642.7724.45
Long-Term Deferred Charges
66.5956.4680.0365.0469.7659.48
Other Long-Term Assets
14.9544.5932.8339.4129.6621.33
Total Assets
6,6537,1555,7726,3014,8564,306
Accounts Payable
253.43288.37130.46320.08399.99299.51
Accrued Expenses
45.09201.41193.5229.74184.01190.59
Short-Term Debt
0.0114.854.26208.4219.14101
Current Portion of Long-Term Debt
----12.539.07
Current Portion of Leases
5.015.4119.0116.8628.24-
Current Income Taxes Payable
7.4442.621.8458.734.6952.69
Current Unearned Revenue
71.7877.172.88236.3180.5597.68
Other Current Liabilities
38.45191.7342.2970.9162.442.9
Total Current Liabilities
421.2821.46484.231,141791.54793.45
Long-Term Debt
581.26570.97552.84532.49510.69501.03
Long-Term Leases
10.2514.3327.6911.1910.420.78
Long-Term Unearned Revenue
39.1547.9437.2123.19.48.11
Long-Term Deferred Tax Liabilities
40.1749.6655.1255.7529.79.1
Total Liabilities
1,0921,5041,1571,7641,3521,312
Common Stock
468.08481.42444.52444.51444.95342.57
Additional Paid-In Capital
1,3061,458765.52775.53787.01866
Retained Earnings
3,7483,8073,4333,1662,1011,637
Treasury Stock
-0.28-171.02-132.46-157.3-139.25-127.56
Comprehensive Income & Other
-21.36-21.295.9115.39159.18123.98
Total Common Equity
5,5005,5544,5164,3443,3532,842
Minority Interest
60.0395.998.66193.8150.97151.33
Shareholders' Equity
5,5605,6504,6154,5383,5042,994
Total Liabilities & Equity
6,6537,1555,7726,3014,8564,306
Total Debt
596.52605.57603.8768.96581.01611.89
Net Cash (Debt)
1,0151,5921,5821,532987.87899.02
Net Cash Growth
-33.56%0.65%3.27%55.07%9.88%-3.83%
Net Cash Per Share
2.143.433.573.472.232.04
Filing Date Shares Outstanding
462.68477.87440.96441.26444.95445.34
Total Common Shares Outstanding
462.68477.87440.96441.26444.95445.34
Working Capital
2,8542,9642,7492,2091,7941,477
Book Value Per Share
11.8911.6210.249.847.546.38
Tangible Book Value
5,1645,2374,2104,0253,1022,614
Tangible Book Value Per Share
11.1610.969.559.126.975.87
Buildings
-1,007530.37447.3436.03202.5
Machinery
-1,0711,021940.43741.37575.35
Construction In Progress
-5.12290.84199.1416.38156.18
Source: S&P Global Market Intelligence. Standard template. Financial Sources.